Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Maria Thompson

Maria Thompson, PhD has a background in molecular genetics and over 16 years of experience in pharmaceutical and diagnostics research and development. She has held a variety of roles including Head of Genome Wide Screening for Type 2 diabetes, Six Sigma Black Belt, and VP of Scientific Affairs. Dr. Thompson is a Principal Consultant at APEX Think, a private consulting company providing scientific and technical advisory services to clients across the life science industry. Dr. Thompson holds a BSc in Genetics and a PhD in Molecular and Cellular Biochemistry from the Royal London School of Medicine, UK.
Showing 41-50 of 78 post
May 28, 2013

We’ve covered the importance of tactical vs strategic outsourcing and the potential for savings and innovation by outsourcing, and now we’ll be...

May 23, 2013

Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke. As a common underlying factor in so many preventable...

May 21, 2013

In the past 10 years, we’ve experienced a shift: the move from in-person to virtual interactions. Email, Facebook, Twitter, and a slew of other...

May 9, 2013

Innovative research is being performed in universities worldwide. There is a quest for knowledge, glory, and most importantly, helping the sick. On...

Apr 30, 2013

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Apr 24, 2013

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

Apr 18, 2013

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

Apr 16, 2013

The health and behavior of each one of our cells is influenced by both genetics and epigenetics. Drug discovery has historically targeted proteins...

Apr 11, 2013

We’ve established that near sourcing has its advantages over outsourcing, but what are the best areas to near source? CROs, biotechs, and pharmas...

Apr 9, 2013

What is the most successful preclinical strategy for drug discovery? Finding the answer to this question is important if pharma is to keep its...